Dehydroepiandrosterone pretreatment alters the ischaemia/reperfusion- induced VEGF, IL-1 and IL-6 gene expression in acute renal failure

Kidney and Blood Pressure Research

Volumn 32, Issue 3, 2009, Pages 175-184

  Vannay, Ádám ^a   Fekete, Andrea ^a   Langer, Róbert ^a   Tóth, Tibor ^a   Sziksz, Erna ^a   Vásárhelyi, Barna ^a   Szabó, Attila J ^a   Losonczy, György ^a   Ádori, Csaba ^b   Gál, Anikó ^a   Tulassay, Tivadar ^a   Szabó, András ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b NATIONAL INSTITUTE OF PSYCHIATRY AND NEUROLOGY   (Hungary)

Author keywords

Dehydroepiandrosterone; Interleukin 1 ; Interleukin 6; Ischaemia reperfusion; Vascular endothelial growth factor

Indexed keywords

CASPASE 3; CREATININE; INTERLEUKIN 1BETA; INTERLEUKIN 6; MESSENGER RNA; PRASTERONE; PRASTERONE SULFATE; VASCULOTROPIN;

ACUTE KIDNEY FAILURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD CHEMISTRY; CHEMICAL LABELING; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG BLOOD LEVEL; DRUG MECHANISM; GENE EXPRESSION; HISTOPATHOLOGY; KIDNEY FUNCTION; KIDNEY INJURY; KIDNEY ISCHEMIA; KIDNEY PARENCHYMA; KIDNEY STRUCTURE; MALE; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; RAT; REPERFUSION INJURY; UREA NITROGEN BLOOD LEVEL;

ACUTE KIDNEY INJURY; ANIMALS; DEHYDROEPIANDROSTERONE; GENE EXPRESSION REGULATION; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; INTERLEUKIN-1; INTERLEUKIN-6; MALE; PREMEDICATION; RATS; RATS, WISTAR; REPERFUSION INJURY; RNA, MESSENGER; TREATMENT OUTCOME; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 66749090405     PISSN: 14204096     EISSN: None     Source Type: Journal    
DOI: 10.1159/000224629     Document Type: Article

References (52)

1. Schrier RW, Wang W, Poole B, Mitra A: Acute renal failure: definitions, diagnosis, pathogenesis, and therapy. J Clin Invest 2004;114:5-14. (Pubitemid 39071636)
2. Muller V, Szabo A, Viklicky O, et al: Sex hormones and gender-related differences: their influence on chronic renal allograft rejection. Kidney Int 1999;55:2011-2020. (Pubitemid 29197991)
3. Park KM, Kim JI, Ahn Y, Bonventre AJ, Bonventre JV: Testosterone is responsible for enhanced susceptibility of males to ischemic renal injury. J Biol Chem 2004;279:52282-52292. (Pubitemid 39656602)
4. Kim J, Kil IS, Seok YM, et al: Orchiectomy attenuates post-ischemic oxidative stress and ischemia/reperfusion injury in mice: a role for manganese superoxide dismutase. J Biol Chem 2006;281:20349-20356. (Pubitemid 44065809)
5. Aragno M, Parola S, Brignardello E, et al: Dehydroepiandrosterone prevents oxidative injury induced by transient ischemia/reperfusion in the brain of diabetic rats. Diabetes 2000;49:1924-1931. (Pubitemid 30812927)
6. Aragno M, Cutrin JC, Mastrocola R, et al: Oxidative stress and kidney dysfunction due to ischemia/reperfusion in rat: attenuation by dehydroepiandrosterone. Kidney Int 2003;64:836-843. (Pubitemid 37013819)
7. Lohman R, Yowell R, Barton S, Araneo B, Siemionow M: Dehydroepiandrosterone protects muscle flap microcirculatory hemodynamics from ischemia/reperfusion injury: an experimental in vivo study. J Trauma 1997;42:74-80. (Pubitemid 27045055)
8. Ayhan S, Tugay C, Norton S, Araneo B, Siemionow M: Dehydroepiandrosterone protects the microcirculation of muscle flaps from ischemia-reperfusion injury by reducing the expression of adhesion molecules. Plast Reconstr Surg 2003;111:2286-2294. (Pubitemid 36676807)
9. Simoncini T, Mannella P, Fornari L, Varone G, Caruso A, Genazzani AR: Dehydroepiandrosterone modulates endothelial nitric oxide synthesis via direct genomic and nongenomic mechanisms. Endocrinology 2003;144:3449-3455. (Pubitemid 36904421)
10. Flores J, DiBona DR, Beck CH, Leaf A: The role of cell swelling in ischemic renal damage and the protective effect of hypertonic solute. J Clin Invest 1972;51:118-126.
11. Summers WK, Jamison RL: The no reflow phenomenon in renal ischemia. Lab Invest 1971;25:635-643.
12. Basile DP, Donohoe D, Roethe K, Osborn JL: Renal ischemic injury results in permanent damage to peritubular capillaries and influences long-term function. Am J Physiol Renal Physiol 2001;281:F887-F899. (Pubitemid 33123835)
13. Sutton TA, Fisher CJ, Molitoris BA: Microvascular endothelial injury and dysfunction during ischemic acute renal failure. Kidney Int 2002;62:1539-1549. (Pubitemid 35286261)
14. Gloddek J, Pagotto U, Paez Pereda M, Arzt E, Stalla GK, Renner U: Pituitary adenylate cyclase-activating polypeptide, interleukin-6 and glucocorticoids regulate the release of vascular endothelial growth factor in pituitary folliculostellate cells. J Endocrinol 1999;160:483-490. (Pubitemid 29182840)
15. Dankbar B, Padro T, Leo R, et al: Vascular endothelial growth factor and interleukin-6 in paracrine tumor-stromal cell interactions in multiple myeloma. Blood 2000;95:2630-2636. (Pubitemid 30210543)
16. Levitas E, Chamoun D, Udoff LC, Ando M, Resnick CE, Adashi EZ: Periovulatory and interleukin-1 beta-dependent up-regulation of intraovarian vascular endothelial growth factor (VEGF) in the rat: potential role for VEGF in the promotion of periovulatory angiogenesis and vascular permeability. J Soc Gynecol Invest 2000;7:51-60. (Pubitemid 30109323)
17. Kenny D, McCarthy-Kenny G, Pelc LR, Cheung HS, Brooks HL, Warltier DC: Vasodilator actions of interleukin-1 in the canine coronary circulation. Basic Res Cardiol 1990;85:279-284. (Pubitemid 20202406)
18. Fukushima R, Saito H, Taniwaka K, et al: Different roles of IL-1 and TNF on hemodynamics and interorgan amino acid metabolism in awake dogs. Am J Physiol 1992;262:E275-E281.
19. Maruo N, Morita I, Ishizaki Y, Murota S: Inhibitory effects of interleukin 6 on prostaglandin I 2 production in cultured bovine vascular endothelial cells. Arch Biochem Biophys 1992;292:600-604.
20. Wen FQ, Watanabe K, Yoshida M: Inhibitory effects of interleukin-6 on release of PGI 2 by cultured human pulmonary artery smooth muscle cells. Prostaglandins 1996;52:93-102. (Pubitemid 26314920)
21. Murohara T, Horowitz JR, Silver M, et al: Vascular endothelial growth factor/vascular permeability factor enhances vascular permeability via nitric oxide and prostacyclin. Circulation 1998;97:99-107. (Pubitemid 28036160)
22. Kolyada AZ, Madias NE: Transcriptional regulation of the human iNOS gene by IL-1beta in endothelial cells. Mol Med 2001;7:329-343. (Pubitemid 33701983)
23. Walch L, Morris PL: Cyclooxygenase 2 pathway mediates IL-1beta regulation of IL-1alpha, -1beta, and IL-6 mRNA levels in Leydig cell progenitors. Endocrinology 2002;143:3276-3283.
24. Gerber HP, Dixit V, Ferrara N: Vascular endothelial growth factor induces expression of the antiapoptotic proteins Bcl-2 and A 1 in vascular endothelial cells. J Biol Chem 1998;273:13313-13316. (Pubitemid 28246905)
25. Kanellis J, Fraser S, Katerelos M, Power DA: Vascular endothelial growth factor is a survival factor for renal tubular epithelial cells. Am J Physiol Renal Physiol 2000;278:F905-F915. (Pubitemid 30441356)
26. Vannay A, Fekete A, Adori C, et al: Divergence of renal vascular endothelial growth factor mRNA expression and protein level in post-ischaemic rat kidneys. Exp Physiol 2004;89:435-444. (Pubitemid 39023184)
27. Vannay A, Fekete A, Muller V, et al: Effects of histamine and the H 2 receptor antagonist ranitidine on ischemia-induced acute renal failure: involvement of IL-6 and vascular endothelial growth factor. Kidney Blood Press Res 2004;27:105-113. (Pubitemid 38594562)
28. Vasarhelyi B, Bencsik P, Treszl A, Bardoczy Z, Tulassay T, Szathmari M: The effect of physiologic hyperinsulinemia during an oral glucose tolerance test on the levels of dehydroepiandrosterone (DHEA) and its sulfate (DHEAS) in healthy young adults born with low and with normal birth weight. Endocr J 2003;50:689-695. (Pubitemid 38139952)
29. Siegling A, Lehmann M, Platzer C, Emmrich F, Volk HD: A novel multispecific competitor fragment for quantitative PCR analysis of cytokine gene expression in rats. J Immunol Methods 1994;177:23-28.
30. Strehlau J, Pavlakis M, Lipman M, et al: Quantitative detection of immune activation transcripts as a diagnostic tool in kidney transplantation. Proc Natl Acad Sci USA 1997;94:695-700. (Pubitemid 27053696)
31. Shilkaitis A, Green A, Punj V, Steele V, Lubet R, Christov K: Dehydroepiandrosterone inhibits the progression phase of mammary carcinogenesis by inducing cellular senescence via a p16-dependent but p53-independent mechanism. Breast Cancer Res 2005;7:R1132-R1140.
32. Wang TT, Hursting SD, Perkins SN, Phang JM: Effects of dehydroepiandrosterone and calorie restriction on the Bcl-2/Bax-mediated apoptotic pathway in p53-deficient mice. Cancer Lett 1997;116:61-69.
33. Lapchak PA, Chapman DF, Nunez SY, Zivin JA: Dehydroepiandrosterone sulfate is neuroprotective in a reversible spinal cord ischemia model: possible involvement of GABA(A) receptors. Stroke 2000;31:1953-1956.
34. Mastrocola R, Aragno M, Betteto S, Brignardello E, Catalano MG, Danni O, Boccuzzi G: Pro-oxidant effect of dehydroepiandrosterone in rats is mediated by PPAR activation. Life Sci 2003;73:289-299. (Pubitemid 36579171)
35. Aragno M, Tamagno E, Gatto V, Brignardello E, Parola S, Danni O, Boccuzzi G: Free dehydroepiandrosterone protects tissues of streptozotocin-treated rats against oxidative stress. Radic Biol Med 1999;26:1467-1474. (Pubitemid 29302278)
36. Muller V, Losonczy G, Heemann U, et al: Sexual dimorphism in renal ischemia-reperfusion injury in rats: possible role of endothelin. Kidney Int 2002;62:1364-1371.
37. Sabbatini M, Santillo M, Pisani A, et al: Inhibition of Ras/ERK1/2 signaling protects against postischemic renal injury. Am J Physiol Renal Physiol 2006;290:F1408-F1415. (Pubitemid 43830766)
38. Venkatachalam MA, Rennke HG, Sandstrom DJ: The vascular basis for acute renal failure in the rat: preglomerular and postglomerular vasoconstriction. Circ Res 1976;38:267-279.
39. Zhao B, Stavchansky SA, Bowden RA, Bowman PD: Effect of interleukin-1beta and tumor necrosis factor-alpha on gene expression in human endothelial cells. Am J Physiol Cell Physiol 2003;284:C1577-C1583. (Pubitemid 36583399)
40. Haq M, Norman J, Saba SR, Ramirez G, Rabb H: Role of IL-1 in renal ischemic reperfusion injury. J Am Soc Nephrol 1998;9:614-619. (Pubitemid 28186050)
41. Kipper-Galperin M, Galilly R, Danenberg HD, Brenner T: Dehydroepiandrosterone selectively inhibits production of tumor necrosis factor alpha and interleukin-6 in astrocytes. Int J Dev Neurosci 1999;17:765-775. (Pubitemid 29488554)
42. Aragno M, Mastrocola R, Brignardello E, et al: Dehydroepiandrosterone modulates nuclear factor-kappaB activation in hippocampus of diabetic rats. Endocrinology 2002;143:3250-3258. (Pubitemid 34925699)
43. Iwasaki Y, Asai M, Yoshida M, Nigawara T, Kambayashi M, Nakashima N: Dehydroepiandrosterone-sulfate inhibits nuclear factor-kappaB- dependent transcription in hepatocytes, possibly through antioxidant effect. J Clin Endocrinol Metab 2004;89:3449-3454. (Pubitemid 38951919)
44. Hiscott J, Marois J, Garoufalis J, et al: Characterization of a functional NF-kappa B site in the human interleukin 1 beta promoter: evidence for a positive autoregulatory loop. Mol Cell Biol 1993;13:6231-6240.
45. Matsui H, Ihara Y, Fujio Y, et al: Induction of interleukin (IL)-6 by hypoxia is mediated by nuclear factor (NF)-kappa B and NF-IL6 in cardiac myocytes. Cardiovasc Res 1999;42:104-112. (Pubitemid 29167075)
46. Libermann TA, Baltimore D: Activation of interleukin-6 gene expression through the NF-kappa B transcription factor. Mol Cell Biol 1990;10:2327-2334. (Pubitemid 20138854)
47. Qian D, Lin HY, Wang HM, et al: Normoxic induction of the hypoxic-inducible factor-1 alpha by interleukin-1 beta involves the extracellular signal-regulated kinase 1/2 pathway in normal human cytotrophoblast cells. Biol Reprod 2004;70:1822-1827. (Pubitemid 38715640)
48. Yamagiwa Y, Marienfeld C, Meng F, Holcik M, Patel T: Translational regulation of X-linked inhibitor of apoptosis protein by interleukin-6: a novel mechanism of tumor cell survival. Cancer Res 2004;64:1293-1298. (Pubitemid 38235596)
49. Crew JP, Fuggle S, Bicknell R, Cranston DW, de Benedetti A, Harris AL: Eukaryotic initiation factor-4E in superficial and muscle invasive bladder cancer and its correlation with vascular endothelial growth factor expression and tumour progression. Br J Cancer 2000;82:161-166. (Pubitemid 30008976)
50. Shima DT, Deutsch U, D'Amore PA: Hypoxic induction of vascular endothelial growth factor (VEGF) in human epithelial cells is mediated by increases in mRNA stability. FEBS Lett 1995;370:203-208.
51. Levy NS, Chung S, Furneaux H, Levy AP: Hypoxic stabilization of vascular endothelial growth factor mRNA by the RNA-binding protein HuR. J Biol Chem 1998;273:6417-6423. (Pubitemid 28144735)
52. Stein I, Itin A, Einat P, Skaliter R, Grossman Z, Keshet E: Translation of vascular endothelial growth factor mRNA by internal ribosome entry: implications for translation under hypoxia. Mol Cell Biol 1998;18:3112-3119. (Pubitemid 28240484)